Art Attack Creative, Inc. – Trademark Portfolio
Entity Type: 03
Art Attack Creative, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AXIO. The owner is based in Colorado Springs, CO.
715 North Weber Street
Colorado Springs, CO 80903
Showing of trademarks Trademarks
Trademark Classifications
Art Attack Creative, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Art Attack Creative, Inc. have?
Art Attack Creative, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.
What trademark classes does Art Attack Creative, Inc. file in?
Art Attack Creative, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Art Attack Creative, Inc.'s most well-known trademarks?
Art Attack Creative, Inc.'s registered trademark portfolio includes well-known marks such as AXIO. These are among 1 currently registered trademark in the portfolio.
What is Art Attack Creative, Inc.'s trademark registration success rate?
Art Attack Creative, Inc. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.